In vivo chemical exchange saturation transfer imaging allows early detection of a therapeutic response in glioblastoma
暂无分享,去创建一个
Edward Pan | Robert M. Bachoo | Osamu Togao | Kimmo J. Hatanpaa | A. Dean Sherry | E. Maher | O. Togao | Masaya Takahashi | T. Mashimo | R. Bachoo | K. Hatanpaa | A. Sherry | B. Mickey | Vamsidhara Vemireddy | E. Pan | Koji Sagiyama | Tomoyuki Mashimo | Vamsidhara Vemireddy | Elizabeth A. Maher | Bruce E. Mickey | Masaya Takahashi | Koji Sagiyama | V. Vemireddy
[1] V. L. Doyle,et al. Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy , 2003, Magnetic resonance in medicine.
[2] O. Togao,et al. Characterization of Lung Cancer by Amide Proton Transfer (APT) Imaging: An In-Vivo Study in an Orthotopic Mouse Model , 2013, PloS one.
[3] A. Goldberg,et al. Protein degradation and the generation of MHC class I-presented peptides. , 2002, Advances in immunology.
[4] P. Loehrer. Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma , 2006 .
[5] L. Recht,et al. Advances in the management of glioblastoma: the role of temozolomide and MGMT testing , 2012, Clinical pharmacology : advances and applications.
[6] Xavier Golay,et al. Amide proton transfer imaging of human brain tumors at 3T , 2006, Magnetic resonance in medicine.
[7] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[8] M. Mrugala,et al. Mechanisms of Disease: temozolomide and glioblastoma—look to the future , 2008, Nature Clinical Practice Oncology.
[9] Dorothee P. Auer,et al. Quantitative imaging biomarkers in neuro-oncology , 2009, Nature Reviews Clinical Oncology.
[10] T. Mak,et al. Regulation of cancer cell metabolism , 2011, Nature Reviews Cancer.
[11] Wei Chen,et al. Predicting treatment response of malignant gliomas to bevacizumab and irinotecan by imaging proliferation with [18F] fluorothymidine positron emission tomography: a pilot study. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] Hiroto Hatabu,et al. MR imaging at high magnetic fields. , 2003, European journal of radiology.
[13] O. Togao,et al. Modulation of water exchange in Eu(III) DOTA-tetraamide complexes: considerations for in vivo imaging of PARACEST agents. , 2009, Contrast media & molecular imaging.
[14] E. Maher,et al. The Telomerase Antagonist, Imetelstat, Efficiently Targets Glioblastoma Tumor-Initiating Cells Leading to Decreased Proliferation and Tumor Growth , 2010, Clinical Cancer Research.
[15] Jinyuan Zhou,et al. Practical data acquisition method for human brain tumor amide proton transfer (APT) imaging , 2008, Magnetic resonance in medicine.
[16] Dieta Brandsma,et al. Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas. , 2008, The Lancet. Oncology.
[17] M. Okada,et al. Targeting JNK for therapeutic depletion of stem-like glioblastoma cells , 2012, Scientific Reports.
[18] J. Bryant,et al. Pathobiology of preoperative chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel (NSABP) protocol B-18. , 2002, Cancer.
[19] K. Anderson,et al. Intracellular Protein Degradation and Its Therapeutic Implications , 2005, Clinical Cancer Research.
[20] Jinyuan Zhou,et al. Amide proton transfer imaging of 9L gliosarcoma and human glioblastoma xenografts , 2008, NMR in biomedicine.
[21] J. Bryant,et al. Pathobiology of preoperative chemotherapy , 2002 .
[22] R. Shah,et al. Role of poly(ADP-ribose) polymerase in rapid intracellular acidification induced by alkylating DNA damage , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[23] Jinyuan Zhou,et al. Amide proton transfer (APT) contrast for imaging of brain tumors , 2003, Magnetic resonance in medicine.
[24] R. Deberardinis,et al. Glucose metabolism via the pentose phosphate pathway, glycolysis and Krebs cycle in an orthotopic mouse model of human brain tumors , 2012, NMR in biomedicine.
[25] Comparison of spin-echo MR pulse sequences for imaging of the brain. , 1997, AJNR. American journal of neuroradiology.
[26] J. Gore,et al. Amide proton transfer imaging of the human breast at 7T: development and reproducibility , 2013, NMR in biomedicine.
[27] R. Mirimanoff,et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. , 2009, The Lancet. Oncology.
[28] Santosh Kesari,et al. Malignant gliomas in adults. , 2008, The New England journal of medicine.
[29] Jinyuan Zhou,et al. MR imaging of high-grade brain tumors using endogenous protein and peptide-based contrast , 2010, NeuroImage.
[30] R. Mirimanoff,et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. , 2005, The New England journal of medicine.
[31] Jinyuan Zhou,et al. Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI , 2003, Nature Medicine.
[32] D. Born,et al. Pseudoprogression: Relevance With Respect to Treatment of High-Grade Gliomas , 2011, Current treatment options in oncology.
[33] Robert E Lenkinski,et al. CEST: from basic principles to applications, challenges and opportunities. , 2013, Journal of magnetic resonance.
[34] H. Sambrook. Molecular cloning : a laboratory manual. Cold Spring Harbor, NY , 1989 .
[35] Koji Yamashita,et al. Amide proton transfer imaging of adult diffuse gliomas: correlation with histopathological grades. , 2014, Neuro-oncology.
[36] A G Sorensen,et al. Pseudoprogression and Pseudoresponse: Imaging Challenges in the Assessment of Posttreatment Glioma , 2011, American Journal of Neuroradiology.
[37] J. Fleiss,et al. Intraclass correlations: uses in assessing rater reliability. , 1979, Psychological bulletin.
[38] R. Bjerkvig,et al. Molecular mechanisms of temozolomide resistance in glioblastoma multiforme , 2012, Expert review of anticancer therapy.
[39] D. Heitjan,et al. 31P and 1H MRS of DB‐1 melanoma xenografts: lonidamine selectively decreases tumor intracellular pH and energy status and sensitizes tumors to melphalan , 2013, NMR in biomedicine.
[40] Erik Tryggestad,et al. Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptides , 2010, Nature Medicine.
[41] A. Sherry,et al. Imaging the tissue distribution of glucose in livers using a PARACEST sensor , 2008, Magnetic resonance in medicine.
[42] R. Mirimanoff,et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.
[43] J. H. Price,et al. Morphological effects of chemotherapy on ovarian carcinoma. , 2002, Journal of clinical pathology.
[44] C. Bailly,et al. Relation between intracellular acidification and camptothecin-induced apoptosis in leukemia cells. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[45] A. Seth,et al. The ubiquitin-mediated protein degradation pathway in cancer: therapeutic implications. , 2004, European journal of cancer.
[46] Susumu Mori,et al. Mechanism of magnetization transfer during on‐resonance water saturation. A new approach to detect mobile proteins, peptides, and lipids , 2003, Magnetic resonance in medicine.
[47] A. Eastman,et al. Etoposide-induced apoptosis in human HL-60 cells is associated with intracellular acidification. , 1993, Cancer research.
[48] Peter C M van Zijl,et al. MRI detection of glycogen in vivo by using chemical exchange saturation transfer imaging (glycoCEST) , 2007, Proceedings of the National Academy of Sciences.
[49] H. Uramoto,et al. Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy. , 2003, Cancer treatment reviews.
[50] Maria I. Argyropoulou,et al. Glioma recurrence versus radiation necrosis: accuracy of current imaging modalities , 2009, Journal of Neuro-Oncology.